https://www.tipranks.com/news/the-fly/trulieve-cannabis-price-target-lowered-to-21-from-24-at-seaport-research Seaport Research analyst Sonny Randhawa lowered the firm’s price target on Trulieve Cannabis (TCNNF) to $21 from $24 and keeps a Buy rating on the shares. The company has a dominant position in the Florida medical market and a strong balance sheet that should create shareholder value for years, the analyst tells investors Discover the Best Stocks and Maximize Your Portfolio: See what stocks are receiving Strong Buy ratings from top-rated analysts. Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on TCNNF: Trulieve Cannabis upgraded to Speculative Buy from Market Perform at Cormark Trulieve Cannabis Reports Strong 2024 Financial Results Trulieve Cannabis Reports Strong Earnings Amidst Challenges Trulieve Launches Onward: A Premium THC Beverage Line Trulieve Expands Ohio Presence with New Columbus Dispensary View Comments
Trulieve Cannabis price target lowered to $21 from $24 at Seaport Research
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...